Very nice. love the bit at the end
BARD1 is currently in discussions with a number of contract laboratory organisations that have specialty expertise in assay development and validation to transfer the BARD1 research essay to a commercial platform that will enable the BARD1 tests to be performed by most hospital and independent clinical laboratories around the world. “BARD1 anticipates that transfer of our research assay to a commercial platform will enable more efficient development and commercialisation of our diagnostic pipeline for detection of lung, ovarian and other cancers,” said Dr Leearne Hinch, BARD1 CEO.
When this happens this will blow.
patience, long term hold will be rewarded.
Ann: Additional BARD1 Ovarian Test Results, page-2
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.015(3.00%) |
Mkt cap ! $44.62M | |||
| Open | High | Low | Value | Volume |
| 50.0¢ | 50.0¢ | 48.5¢ | $3.031K | 6.133K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 6396 | 1 |
View Market Depth
| Last trade - 15.27pm 07/05/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |